299 related articles for article (PubMed ID: 22535601)
41. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
Nagendra S; Meyerson H; Skallerud G; Rosenthal N
Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
[TBL] [Abstract][Full Text] [Related]
42. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
43. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
[TBL] [Abstract][Full Text] [Related]
44. [Application of immunophenotypic analysis and molecular genetics in the diagnosis of acute promyelocytic leukemia].
Gong JY; Li YY; Li CW; Wang YS; Liu Y; Wang C; Ru K; Mi YC; Wang JX; Wang HJ
Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):288-293. PubMed ID: 31104439
[No Abstract] [Full Text] [Related]
45. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
[TBL] [Abstract][Full Text] [Related]
46. A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype.
Stasi R; Bruno A; Venditti A; Del Poeta G; Aronica G; Cox MC; Maffei L; Catalano G; Zangrilli D; Amadori S
Leuk Res; 1997 Jun; 21(6):575-80. PubMed ID: 9279368
[TBL] [Abstract][Full Text] [Related]
47. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
[TBL] [Abstract][Full Text] [Related]
48. Identification of cell lineages involved by t(15;17) in acute promyelocytic leukemia by combined fluorescence activated cell sorting and FISH.
Chang H; Qi XY; Sutherland DR
Cancer Genet Cytogenet; 2005 Apr; 158(1):43-8. PubMed ID: 15771903
[TBL] [Abstract][Full Text] [Related]
49. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.
Terstappen LW; Safford M; Könemann S; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
Leukemia; 1992 Jan; 6(1):70-80. PubMed ID: 1540262
[TBL] [Abstract][Full Text] [Related]
50. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
51. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
53. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
[TBL] [Abstract][Full Text] [Related]
54. Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis.
Schwonzen M; Diehl V; Dellanna M; Staib P
Leuk Res; 2007 Jan; 31(1):113-6. PubMed ID: 16730795
[TBL] [Abstract][Full Text] [Related]
55. Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia.
Edwards RH; Wasik MA; Finan J; Rodriguez R; Moore J; Kamoun M; Rennert H; Bird J; Nowell PC; Salhany KE
Am J Clin Pathol; 1999 Dec; 112(6):819-27. PubMed ID: 10587705
[TBL] [Abstract][Full Text] [Related]
56. Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH.
Han JY; Kim KE; Kim KH; Park JI; Kim JS
Leuk Res; 2007 Feb; 31(2):239-43. PubMed ID: 16797070
[TBL] [Abstract][Full Text] [Related]
57. Flow cytometric analysis of CD64 expression pattern and density in the diagnosis of acute promyelocytic leukemia: a multi-center study in Shanghai, China.
Liu M; Weng X; Gong S; Chen H; Ding J; Guo M; Hu X; Wang J; Yang J; Tang G
Oncotarget; 2017 Oct; 8(46):80625-80637. PubMed ID: 29113330
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid.
Horna P; Zhang L; Sotomayor EM; Lancet JE; Moscinski LC
Am J Clin Pathol; 2014 Oct; 142(4):546-52. PubMed ID: 25239423
[TBL] [Abstract][Full Text] [Related]
59. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia.
Lee JJ; Cho D; Chung IJ; Cho SH; Park KS; Park MR; Ryang DW; Kim HJ
Am J Hematol; 2003 Jul; 73(3):149-53. PubMed ID: 12827650
[TBL] [Abstract][Full Text] [Related]
60. Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation.
Arana Rosainz MJ; Nguyen N; Wahed A; Lelenwa LC; Aakash N; Schaefer K; Rios A; Kanaan Z; Chen L
Int J Lab Hematol; 2021 Apr; 43(2):218-226. PubMed ID: 33099879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
